PHAT Q4 2023 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$682,000

Gross Profit

$330,00048.4% margin

Operating Income

-$70M-10245.5% margin

Net Income

-$80M-11667.0% margin

EPS (Diluted)

$-1.39

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$414M

Total Liabilities

$487M

Stockholders' Equity

-$73M

Cash & Equivalents

$381M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$682,000	$0	—
Gross Profit	$330,000	-$168,000	+296.4%
Operating Income	-$70M	-$47M	-49.8%
Net Income	-$80M	-$55M	-44.5%